Anavex Life Sciences Corp (AVXL)

[Gator328]

I vacillate between whether I believe in AVXL for the long-term. On one hand the data all points that the drug works. On the other hand, the stock market and my gut tell me that the odds are heavily against P3 approval.

What I do know is that the short-term outlook is pointing up. It broke the 2.80 support but has been holding 2.50 well which is exactly what it needed to do from a long-term perspective -- if you go back to 2015/2016 this is right around the level of support it had previously held.

I discount the Dec 2019 crash because the entire market was down on account of trade war and interest rate fears.